Introduction
Haemoglobin is a complex molecule contained within erythrocytes that binds to and transports oxygen and carbon dioxide in the body. Normal alpha 2 beta 2 chain genes for globin chain synthesis are located in two clusters on chromosome 11 & 16 . Genetic mutation causes reduced synthesis of beta chain to ineffective erythropoesis causing reduced hemoglobin. Defects in genes of haemoglobin can produce abnormal haemoglobins and anemia, which leads to conditions, termed as "haemoglobinopathies". Abnormal haemoglobins appear in one of two basic circumstances: decreased production of one of the globin chain e.g. thalassaemia, abnormal globin chain e.g. sickle cell disease. 1 Abnormalities of hemoglobin (Hb) synthesis are among the most common inherited disorders of man and can be quantitative (thalassemia syndrome) or qualitative (variant Hb S) 2 . Of these, thalassemia syndromes particularly beta thalassemia major is serious and a major cause of morbidity. WHO figures estimate that 5 % of the world population is a carrier for hemoglobin disorders 3 .The frequency of ß-thalassemia in India ranges from 3.5 to 15 % in general population 4 . Every year 10,000 children with thalassaemia major are born in India, which constitutes 10 % of the total numbers in the world.
5 India spends nearly Rs 1000 crore per annum in the treatment of thalassemia patients. Majority of the centers in India use conventional methods for diagnosis of haemoglobinopathies, which include clinical and family history, red cell indices, complete blood counts (CBC), HbA2, HbF estimation, sickling test and Hb electrophoresis. 6 Electrophoresis of hemoglobin variants with similar mobilities has inherent limitations. The identification of variants is dependent on the technical performance of electrophoresis, which has many variables, e.g., hemoglobin concentration, amperage, running temperature, and length of electrophoresis run. These variables can affect the quality of separation and relative positioning of the bands. Variants that migrate identically or similarly would be very difficult, if not impossible, to evaluate without the unknown sample being electrophoresed directly adjacent to the reference hemoglobin mixture or adjacent to several known stored specimens. HPLC, on the other hand, has been shown to have a high degree of reproducibility and precision. 
II. Material & Methods
Blood sample of suspected cases of gentic disorders were assessed in the department of Laboratory Medicine of RIMS, Ranchi for work up of anemia or other blood related disorders. This blood samples were assessed on BIORAD variant using beta thalassemia short program. A total of 107 cases , in the year 2013 for Hb variant analysis were studied for various hemoglobinopathies and variants. 107 blood samples in the year 2013, were run in 5 parts SYSMAX hemato-analyzer before performing HPLC to obtain the Hemoglobin values and indices. The tests were performed on BIO RAD 'VARIANT II which utilizes the principle of high performance liquid chromatography (HPLC). An Hb A2/F calibrator and two levels of controls (BIO-RAD) were analyzed at the beginning of each run. The total area acceptable was between-one to three million. History of Blood transfusion and relevant family history was taken in all cases. The software delivers a printed report showing the chromatogram, with all the hemoglobin fractions eluted. The integrated peaks are assigned to the manufacturer -defined "windows" derived from the specific retention time (RT). This retention time is the time that elapses from the sample injection to the apex of the elution peak, of normal hemoglobin fraction and common variants ( Table 1) . The "windows" are established ranges in which common variants have been observed. The printed chromatogram shows all the hemoglobin fractions eluted, the retention times, the areas of the peaks and the values (%) of different hemoglobin components. If a peak elutes at a retention time that is not predefined, it is labelled as an unknown. Each analytical cycle, from sampling to printing of results takes about only a few minutes ( about 6.5 minutes).
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Alkaline gel electrophoretic tests was also done in few selected cases just to compare the results. 
III. Results
Laboratory records of 107 patients of anemia with suspected hemoglobinopathies were analyzed and 63 (67.40% %) patients showed different abnormal hemoglobin variants (table 2). Out of total 107 cases, 71 ( 75.97 %) were male and 36 ( 38.52 %) were female. Criteria for suspecting hemoglobinopathy in these cases included: results of screening tests eg., various discriminant functions (so obtained on hematology cell counters, findings obtained from the peripheral smear examination, family history and relevant clinical signs and symptoms suggestive of hemoglobinopathy.44 (47.08%) cases which were labeled as "NoHemoglobinopathies" also included cases of Iron Deficiency anemia & Malaria amongst the other ones having other causes of anemia.The age range of patients was from 1 month to 18 years. Of these 13 (21.1 %) patients were diagnosed to have beta-heterozygous thalassaemia (Table 2) based on the high level of HbA2 (>3.9%). These patients presented with mild anaemia (mean Hb level of 10.4gm/dl) and all showed microcytichypochromic blood picture with low mean corpuscular volume RDWSD < 46 fl , RDW CV < 16 % [(MCV) of <80fl]. 5 (4.6%) of 107 cases were diagnosed as beta -homozygous thalassemia ( Table 2 ). All these patients had increased HbF values ( > 40 %). Clinically they presented with severe pallor requiring regular blood transfusion and had moderate to marked hepatosplenomegaly. 9 
Discussion
Hemoglobinopathies and thalassaemias are common disorders in our country. Appropriate modernized ,well equipped, updated laboratory tests are required for diagnosis and confirmation of these disorders.
The most common investigational tools for diagnosis of hemoglobinopathies and thalassemias are alkaline and acid gel electrophoresis, HbA2 quantification by ion exchange column chromatography and HbF quantification by alkali denaturation method.
The identification of hemoglobin variants by conventional Electrophoretic techniques are often presumptive, based on the electrophoretic mobility of the band, quantification and / or ethnic origin of the parents 6 . The compound heterozygous disorders or unusual variants are all clinically significant with varying degree of severity, making precise identification important 11, 12 , none can be conclusively identified by a single electrophoretic technique 13 . HPLC offers the distinct advantage over classic hemoglobin electrophoresis as it can more accurately identify and quantitate abnormal haemoglobins 14 . It is also very useful for pediatric group of patients, as only 5μl of blood is sufficient for analysis. HPLC has been shown to be rapid, sensitive, specific and reproducible alternative to conventional hemoglobin electrophoresis.
Our study included predominantly patients of Ranchi district. It also includes a few cases from other districts of Jharkhand as RIMS being a Tertiary Care Institute. Out of 107 cases studied, 63 cases (67.40%) displayed various abnormal hemoglobin fractions on HPLC runs. Beta thalassemia trait formed the largest subgroup of abnormal hemoglobin (12.1%). The high incidence of Beta thalassemia trait underscores the need for both the population screening of marriageable age groups ( age of 18) and antenatal screening for prevention of thalassemia major in offspring. History of recent blood transfusion must be sought along with correct age so as to aid in an accurate diagnosis. Conditions with borderline Hb A2 need careful interpretation. Iron deficiency may lead to low Hb A2 and hence may mask a thalassemia trait where as B12/folate deficiency may lead to slightly raised Hb A2 leading to a false diagnosis of a trait.
Hb S homozygous (12 cases) presented with a variant S Window ranging from 70-90% and retention time 4.42 minutes. Sickling test was positive in all such cases. Hb was 7.2 gm/dL with target cells and few irreversibly sickled cells in the peripheral smear. Hb F was in the range of 15-20%. Seventy three cases were diagnosed as Hb S heterozygous having S-window with abnormal hemoglobin ranging from> 50 % . 10 cases were diagnosed as a Sickle trait in which A2 was < 5% & Hb F < 2%. 7 cases of double heterozygous for Hb Sbeta thalassemia trait in which Hb S > 50 % , A2 > 5 % & Hb F > 2 %.
As we know that the Principle of HPLC & Column comprises of a small cation exchange cartridge 8 , This makes an excellent platform for screening hemoglobin variants and hemoglobinopathies along with thalassemias. College of American Pathologists has shown far superiority over electrophoretic methods ( 2003 CAP survey). 15 Although HbS syndromes could be diagnosed by both HPLC and gel electrophoresis, the use of HPLC helped in further sub -characterization of these syndromes based on quantification of HbJ, HbS and HbA2 levels. In general, HbJ syndromes and HbS trait are asymptomatic but patients with sickle cell anemia (Hb SS) are symptomatic. Hb J trait results as P3 peak more than 15 %. elute in unknown peak window on HPLC.
It is thus recommended that HPLC should be definitely be performed for further sub characterization of rare Hb variants 16 . HPLC avoids misidentification of two hemoglobin variants having benign interaction with HbS. With the integration of proper algorithms involving retention time, amount of Hb and RBC indices, a clinical laboratory is capable of identifying about 90 % of the common variants encountered without the need for other studies such as alkaline and acid electrophoresis.
In the long run limitation of electrophoretic technique is higher capital & reagent costs and considerable skill and experience are needed in interpreting the results, as the data produced are quite complex. 17 A disclaimer should always accompany the reports and findings must be supplemented by Hemogram findings, family/sibling studies, other confirmatory techniques and molecular studies based on HPLC findings and on a case-to-case basis.
In conclusion, the simplicity of sample preparation, accurate quantification of hemoglobin concentration combined with complete automation, makes HPLC an ideal methodology for the routine diagnosis of hemoglobin disorders. Hemoglobinopathies exert significant burden on India, especially in our state, Jharkhand. Adequate measures and screening procedures should be adopted to reduce this burden. HPLC and hemato-analyzer an excellent, powerful diagnostic tool for the direct identification of hemoglobin variants with a high degree of precision in the quantification of major and minor, normal and abnormal, hemoglobin fractions. 18 
